Treatment of merkel cell carcinoma
- PMID: 15596922
- DOI: 10.1097/01.coc.0000135567.62750.f4
Treatment of merkel cell carcinoma
Abstract
Purpose: The purpose of this study was to evaluate the treatment of Merkel cell carcinoma.
Materials and methods: We reviewed 85 cases of Merkel cell carcinoma. There were 68 males and 17 females. The majority of cases involved head and neck sites (48%), followed by the extremities (38%) and trunk (14%). Sixty-seven percent of the patients had stage I disease that was localized to the skin of origin at presentation. Twenty-five percent and 8% were stage II (nodal metastasis) and stage III (distant metastasis), respectively. Surgical intervention included local or wide local excision +/- nodal dissection (68%), radical resection +/- nodal dissection (22%), and amputation (4%). Five patients (6%) underwent biopsy only because of metastatic disease or unresectability at presentation. Fifty-one percent received adjuvant therapy consisting of external beam radiation therapy and/or combination chemotherapy.
Results: With an average follow-up time of 39.5 months, 12% had persistent disease and 40% had recurrent disease. The median time to recurrence was 8 months with a mean of 10.6 months. Although the addition of adjuvant therapy did not affect survival, the recurrence rate was 32.5% for surgery +/- adjuvant radiation therapy +/- chemotherapy as compared with 52.7% for surgery-only patients. Although the 40.7% recurrence rate for patients receiving surgery and adjuvant radiation therapy was approximately the same as for patients receiving surgery and adjuvant chemotherapy (40%), the effect of systemic chemotherapy on recurrence is less clear as a result of the small number of patients who received such therapy. Although tumor size and site of presentation were not observed to be statistically significant in overall survival, significant differences were observed based on sex and tumor stage. For females, the median survival time was 96 months (mean, 94.5 months) compared with 63 months (mean, 76.8 months) for males. This difference was significant (P < 0.01). Patients presenting with low-stage (stage I) disease had a significant (P < 0.01) survival benefit when compared with high-stage individuals (stages II and III). The 5-year actuarial survival rates were 68% and 42%, respectively.
Conclusion: In this retrospective study, surgery remains the primary modality for Merkel cell carcinoma, and adjuvant radiation therapy +/- systemic chemotherapy reduces local recurrence. Female patients and those who present with early-stage disease appear to have a better prognosis.
Comment in
-
Adjuvant chemotherapy for Merkel cell carcinoma.Am J Clin Oncol. 2005 Dec;28(6):634. doi: 10.1097/01.coc.0000170803.20722.2d. Am J Clin Oncol. 2005. PMID: 16317279 No abstract available.
Similar articles
-
Analysis of radiation therapy for the control of Merkel cell carcinoma of the head and neck based on 36 cases and a literature review.Ear Nose Throat J. 2008 Nov;87(11):634-43. Ear Nose Throat J. 2008. PMID: 19006065 Review.
-
Merkel cell carcinoma: a clinicopathological study of 11 cases.J Eur Acad Dermatol Venereol. 2005 Sep;19(5):546-51. doi: 10.1111/j.1468-3083.2005.01224.x. J Eur Acad Dermatol Venereol. 2005. PMID: 16164706
-
Merkel cell carcinoma: does tumor size or depth of invasion correlate with recurrence, metastasis, or patient survival?Laryngoscope. 2006 May;116(5):791-5. doi: 10.1097/01.mlg.0000208615.93883.b2. Laryngoscope. 2006. PMID: 16652089
-
Adjuvant Radiation Therapy and Chemotherapy in Merkel Cell Carcinoma: Survival Analyses of 6908 Cases From the National Cancer Data Base.J Natl Cancer Inst. 2016 May 31;108(9):djw042. doi: 10.1093/jnci/djw042. Print 2016 Sep. J Natl Cancer Inst. 2016. PMID: 27245173 Free PMC article.
-
Merkel cell carcinoma: report of 10 cases and review of the literature.J Am Acad Dermatol. 2000 Nov;43(5 Pt 1):755-67. doi: 10.1067/mjd.2000.106505. J Am Acad Dermatol. 2000. PMID: 11050578 Review.
Cited by
-
Merkel Cell Carcinoma of the Head and Neck: Recommendations for Diagnostics and Treatment.Ann Surg Oncol. 2017 Oct;24(11):3430-3437. doi: 10.1245/s10434-017-5993-1. Epub 2017 Jul 31. Ann Surg Oncol. 2017. PMID: 28762116 Free PMC article. Review.
-
Merkel cell tumor of the skin treated with localized radiotherapy: are widely negative margins required?Rare Tumors. 2011 Mar 30;3(1):e12. doi: 10.4081/rt.2011.e12. Rare Tumors. 2011. PMID: 21464874 Free PMC article.
-
Merkel cell carcinoma: chemotherapy and emerging new therapeutic options.J Skin Cancer. 2013;2013:327150. doi: 10.1155/2013/327150. Epub 2013 Feb 10. J Skin Cancer. 2013. PMID: 23476782 Free PMC article.
-
Merkel Cell Carcinoma, Version 1.2018, NCCN Clinical Practice Guidelines in Oncology.J Natl Compr Canc Netw. 2018 Jun;16(6):742-774. doi: 10.6004/jnccn.2018.0055. J Natl Compr Canc Netw. 2018. PMID: 29891526 Free PMC article.
-
Merkel cell carcinoma: epidemiology, clinical features, diagnosis and treatment of a rare disease.An Bras Dermatol. 2023 May-Jun;98(3):277-286. doi: 10.1016/j.abd.2022.09.003. Epub 2023 Mar 2. An Bras Dermatol. 2023. PMID: 36870886 Free PMC article.
MeSH terms
LinkOut - more resources
Full Text Sources
Medical